CVE:COV Covalon Technologies (COV) Stock Price, News & Analysis → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free COV Stock Alerts C$1.34 +0.04 (+3.08%) (As of 03/18/2024 05:17 PM ET) Add Compare Share Share Today's RangeC$1.34▼C$1.3450-Day RangeC$1.01▼C$1.4552-Week RangeC$0.96▼C$2.35Volume100 shsAverage Volume5,858 shsMarket CapitalizationC$33.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesStock AnalysisChartEarningsHeadlines Get Covalon Technologies alerts: Email Address Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. About Covalon Technologies Stock (CVE:COV)Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.Read More COV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart COV Stock News HeadlinesMarch 15, 2024 | americanbankingnews.comCovalon Technologies (CVE:COV) Trading Up 3%March 15, 2024 | americanbankingnews.comCovalon Technologies (CVE:COV) Stock Price Up 3%March 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.February 28, 2024 | ca.finance.yahoo.comCovalon Technologies Ltd. (COV.V)January 26, 2024 | financialpost.comCovalon Announces Management ChangesJanuary 26, 2024 | businesswire.comCovalon Announces Fourth Quarter and Year End Results for Fiscal 2023January 4, 2024 | msn.comCovalon Technologies appoints Brent Ashton as CEOJanuary 4, 2024 | finance.yahoo.comCovalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEOMarch 19, 2024 | InvestorPlace (Ad)They said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.December 23, 2023 | finance.yahoo.comIs Covalon Technologies (CVE:COV) In A Good Position To Deliver On Growth Plans?October 20, 2023 | ca.finance.yahoo.comStocks in play: Covalon Technologies Ltd.October 20, 2023 | finance.yahoo.comCovalon Announces Issuance of Deferred Share UnitsOctober 13, 2023 | finance.yahoo.comCovalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OROctober 11, 2023 | finance.yahoo.comCovalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in ChicagoOctober 10, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd flat on Friday (COV)October 5, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd down on Wednesday (COV)September 25, 2023 | businesswire.comLife with a Central Line [WEBINAR]: Key Considerations from the Patient’s PerspectiveSeptember 14, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd up on Monday (COV)August 24, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd flat on Wednesday (COV)August 18, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd up on Thursday (COV)August 16, 2023 | msn.comCovalon Technologies GAAP EPS of -C$0.02, revenue of C$6.3MJuly 18, 2023 | finance.yahoo.comPremier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access SitesJuly 8, 2023 | finance.yahoo.comIs Covalon Technologies (CVE:COV) In A Good Position To Invest In Growth?July 7, 2023 | theglobeandmail.comClosing Bell: Covalon Technologies Ltd down on Friday (COV)June 27, 2023 | finance.yahoo.comCovalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023May 25, 2023 | finance.yahoo.comCovalon Announces Second Quarter Results for Fiscal 2023May 23, 2023 | finance.yahoo.comCovalon Announces Conference Call to Discuss Second Quarter Fiscal 2023 Financial ResultsSee More Headlines Receive COV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/26/2024Today3/19/2024Next Earnings (Estimated)5/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:COV CUSIPN/A CIKN/A Webwww.covalon.com Phone+1-905-5688400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($0.19) Trailing P/E RatioN/A Forward P/E Ratio4.47 P/E GrowthN/ANet IncomeC$-4,930,000.00 Net Margins-19.67% Pretax MarginN/A Return on Equity-23.98% Return on Assets-13.49% Debt Debt-to-Equity Ratio7.79 Current Ratio4.81 Quick Ratio6.45 Sales & Book Value Annual SalesC$25.07 million Price / Sales1.32 Cash FlowC$0.31 per share Price / Cash Flow4.28 Book ValueC$0.72 per share Price / Book1.86Miscellaneous Outstanding Shares24,670,000Free FloatN/AMarket CapC$33.06 million OptionableNot Optionable Beta0.55 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Brian E. PedlarPresident & DirectorMr. Ronald HebertSenior Vice President of GrowthMr. Amir Boloor CFAExecutive ChairmanMr. Brent AshtonCEO & DirectorDr. Valerio DiTizio (Age 56)Co-Founder, Chief Scientific Officer & VP Comp: $177kMs. Katie MartinovichInterim Chief Financial OfficerMs. Kim CrooksSenior Vice President of OperationsMr. Greg LeszczynskiVice President of Human ResourcesGerry ArambulaPresident of Covalon Technologies AG Ltd.Mr. Hamed AbbasianVice President of Business DevelopmentMore ExecutivesKey CompetitorsDevonian Health GroupCVE:GSDIBEX TechnologiesCVE:IBTAptose BiosciencesTSE:APSHelix BioPharmaTSE:HBPAcasti PharmaCVE:ACSTView All Competitors COV Stock Analysis - Frequently Asked Questions How have COV shares performed in 2024? Covalon Technologies' stock was trading at C$1.06 at the beginning of the year. Since then, COV shares have increased by 26.4% and is now trading at C$1.34. View the best growth stocks for 2024 here. When is Covalon Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024. View our COV earnings forecast. How were Covalon Technologies' earnings last quarter? Covalon Technologies Ltd. (CVE:COV) released its earnings results on Friday, January, 26th. The company reported ($0.12) earnings per share (EPS) for the quarter. The business had revenue of $6.90 million for the quarter. Covalon Technologies had a negative trailing twelve-month return on equity of 23.98% and a negative net margin of 19.67%. What other stocks do shareholders of Covalon Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Covalon Technologies investors own include Shopify (SHOP), Bausch Health Companies (BHC), Carbon Black (CBLK), Great Canadian Gaming (GC), Canada Goose (GOOS), Kirkland Lake Gold (KL), Kinaxis (KXS), Lightspeed Commerce (LSPD), NIO (NIO) and NVIDIA (NVDA). How do I buy shares of Covalon Technologies? Shares of COV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:COV) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Covalon Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.